Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study
| Image |  |
|---|---|
| Description | scientific article published on 04 September 2020 |
| Author/s |
author: Athanasios Dimopoulos Katja Weisel María Victoria Mateos Sebastian Grosicki Hermann Einsele Adam Walter-Croneck Robert Z Orlowski Hila Magen Meral Beksac |
| Publication date | September 4, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |